KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Eli Lilly (LLY) Other Gross PP&E Adjustments (2016 - 2024)

Eli Lilly filings provide 16 years of Other Gross PP&E Adjustments readings, the most recent being $382.0 million for Q4 2024.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 19.45% to $382.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $382.0 million, a 19.45% increase, with the full-year FY2024 number at $382.0 million, up 19.45% from a year prior.
  • Other Gross PP&E Adjustments hit $382.0 million in Q4 2024 for Eli Lilly, up from $319.8 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $382.0 million in Q4 2024 to a low of $226.8 million in Q4 2020.
  • Median Other Gross PP&E Adjustments over the past 5 years was $258.7 million (2021), compared with a mean of $288.8 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: soared 162.55% in 2020 and later decreased 0.81% in 2022.
  • Eli Lilly's Other Gross PP&E Adjustments stood at $226.8 million in 2020, then rose by 14.07% to $258.7 million in 2021, then decreased by 0.81% to $256.6 million in 2022, then grew by 24.63% to $319.8 million in 2023, then grew by 19.45% to $382.0 million in 2024.
  • The last three reported values for Other Gross PP&E Adjustments were $382.0 million (Q4 2024), $319.8 million (Q4 2023), and $256.6 million (Q4 2022) per Business Quant data.